医学
凝血障碍
重症监护医学
凝结
肝病
疾病
临床诊断
临床意义
内科学
血栓形成
临床研究
混凝试验
临床实习
第一行
血栓栓塞性疾病
协商一致会议
治疗方法
临床疾病
胃肠病学
药店
临床判断
临床试验
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-05-20
卷期号:34 (5): 417-429
标识
DOI:10.3760/cma.j.cn501113-20260203-00055
摘要
Coagulation disorders are a major contributing factor to bleeding and thrombotic diseases in patients with liver disease. Furthermore, it is one of the severe complications, which is closely related to disease progression and poor prognosis, affecting various diagnostic and therapeutic procedures in patients with liver disease. Therefore, accurately assessing the coagulation function, maintaining the balance of their coagulation status, and establishing clinical diagnostic and treatment standards for the prevention and treatment of bleeding and thrombosis are of great significance for the liver disease patients' clinical diagnosis and treatment. This consensus is formulated in discussion with experts from fields in hepatology, hematology, critical care medicine, laboratory medicine, and clinical pharmacy in reference to the latest evidence-based medicine with the aim of providing guidance for the clinical diagnosis and treatment of coagulation disorder in patients with liver disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI